Synlett 2011(16): 2355-2358  
DOI: 10.1055/s-0030-1261231
LETTER
© Georg Thieme Verlag Stuttgart ˙ New York

Tributyltin Hydride as a Selective Reducing Agent for Aryl Enones

Marie E. Krafft*, Dinesh V. Vidhani, John W. Cran
Department of Chemistry and Biochemistry, Florida State University, Tallahassee, FL 32306-4390, USA
Fax: +1(850)6447409; e-Mail: mek@chem.fsu.edu;
Further Information

Publication History

Received 10 June 2011
Publication Date:
13 September 2011 (online)

Abstract

Aryl enones undergo selective 1,4-reduction to the corresponding saturated ketones with two equivalents of tributyltin hydride in the presence of a wide range of other potentially reducible functional groups, including alkyl enone. Additionally during this investigation reductive cyclization of bisenones to give five- and six-membered carbocycles via an α,β-coupling process was observed.

12

All commercially procured chemicals were used as received. Dichloromethane, triethylamine, diethyl ether, benzene (C6D6) were distilled from calcium hydride. THF was distilled from lithium aluminum hydride. Reagent grade solvents were used for solvent extraction and organic extracts were dried over anhyd Na2SO4. Silica gel 60 (230-400 mesh ASTM) was used for flash chromatography with anhyd hexane-EtOAc. ¹H NMR spectra were recorded on 500 MHz Varian, 500 MHz Bruker or 300 MHz Varian spectrometers. The proton chemical shifts (δ) are reported as parts per million relative to 7.26 ppm for CDCl3, 7.14 ppm for C6D6, 5.32 for CD2Cl2.
Typical Procedure for the Selective Reduction of Aryl Enones: To a stirred solution of the aryl vinyl ketone (1.0 mmol) in benzene (3.3 mL, 0.3 M) in a resealable tube at r.t. under argon was added tributyltin hydride (0.58 g, 2.0 mmol). The reaction mixture was subsequently heated to 80 ˚C for 3 h. Upon completion the reaction mixture was concentrated en vacuo and purified by flash column chromatography to give the reduced product as a clear oil.

13

NMR data: 1b,¹4 3b,² 4b,¹5 5b,¹6 6b,¹7 7b,¹8 8b,¹9 9b,²0 11b,²¹ 15b,²² 17b and 18b,²³ 17c.²4 Compound 2b: ¹H NMR (300 MHz, CD2Cl2): δ = 7.95 (m, 2 H), 7.55 (m, 1 H), 7.47 (m, 2 H), 6.78 (dt, J = 15.95, 6.9 Hz, 1 H), 6.09 (dd, J = 16.0, 1.4 Hz, 1 H), 2.96 (t, J = 7.2 Hz, 2 H), 2.20 (s, 3 H), 2.09 (tdd, J = 7.0, 7.0, 1.5 Hz, 2 H), 1.71 (tt, J = 7.15, 7.15 Hz, 2 H), 1.29-1.53 (m, 10 H). ¹³C NMR (75 MHz, CD2Cl2): δ = 200.5, 198.6, 148.8, 137.7, 133.2, 131.7, 129.0, 128.4, 38.9, 32.9, 29.9, 29.7, 29.6, 28.6, 27.0, 24.7. Compound 10b: ¹H NMR (300 MHz, CD2Cl2): δ = 9.48 (d, J = 8.0 Hz, 1 H), 7.95 (m, 2 H), 7.55 (m, 1 H), 7.47 (m, 2 H), 6.85 (dt, J = 15.7, 6.6 Hz, 1 H), 6.09 (dd, J = 15.2, 7.7 Hz, 1 H), 2.96 (t, J = 7.2 Hz, 2 H), 2.32 (dt, J = 7.4, 7.2 Hz, 2 H), 1.71 (tt, J = 7.2, 6.9 Hz, 2 H), 1.50 (tt, J = 6.9, 6.9 Hz, 2 H) 1.35 (m, 8 H). ¹³C NMR (75 MHz, CD2Cl2): δ = 200.2, 194.1, 159.17, 137.4, 133.1, 132.9, 128.7, 1281, 38.7, 32.8, 29.6, 29.5, 29.4, 29.3, 28.0, 24.4. Compound 12b: ¹H NMR (300 MHz, CD2Cl2): δ = 7.93 (m, 2 H), 7.55 (m, 1 H), 7.46 (m, 2 H), 6.94 (dt, J = 15.7, 6.9 Hz, 1 H), 5.80 (dd, J = 15.4, 1.4 Hz, 1 H), 3.67 (s, 3 H), 2.94 (t, J = 7.4 Hz, 2 H), 2.19 (tdd, J = 7.9, 6.9, 1.1 Hz, 2 H), 1.71 (tt, J = 7.2, 6.8 Hz, 2 H), 1.24-1.52 (m, 10 H). ¹³C NMR (75 MHz, CD2Cl2): δ = 200.3, 167.1, 149.8, 137.9, 132.9, 128.7, 128.1, 120.9, 51.4, 38.7, 32.3, 29.6, 29.5, 29.4, 29.2, 28.2, 24.4.